Peripheral toxicity in crack cocaine use disorders

Neuroscience Letters

Volumn 544, Issue , 2013, Pages 80-84

  Narvaez, Joana C M ^a,b   Magalhães, Pedro V ^a,b   Fries, Gabriel R ^a,b   Colpo, Gabriela D ^a,b   Czepielewski, Letícia S ^a,b   Vianna, Priscila ^b   Chies, José Artur Bogo ^b   Rosa, Adriane R ^a,b,c   Von Diemen, Lisia ^a,b   Vieta, Eduard ^d   Pechansky, Flávio ^a,b   Kapczinski, Flávio ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Mestrado em Avaliacao de Impactos Ambientais em Mineracao Victor Barreto   (Brazil)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Brain derived neurotrophic factor; Crack cocaine; Inflammation markers; Oxidative damage

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; COCAINE; CYTOKINE; INTERLEUKIN 1BETA;

ADULT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OXIDATIVE STRESS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REWARD;

ADULT; BIOLOGICAL MARKERS; BRAZIL; CAUSALITY; COCAINE-RELATED DISORDERS; COMORBIDITY; CRACK COCAINE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; MALE; RISK ASSESSMENT; RISK FACTORS;

EID: 84878405898     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.03.045     Document Type: Article

References (48)

1. Bashkatova V., Meunier J., Maurice T., Vanin A. Memory impairments and oxidative stress in the hippocampus of in-utero cocaine-exposed rats. Neuroreport 2005, 16:1217-1221.
2. Bekinschtein P., Cammarota M., Izquierdo I., Medina J.H. BDNF and memory formation and storage. Neuroscientist 2008, 14:147-156.
3. Bhunu C.P., Mushayabasa S. Assessing the effects of drug misuse on HIV/AIDS prevalence. Theory Biosci. 2012, 1-10.
4. Cowansage K.K., LeDoux J.E., Monfils M.H. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr. Mol. Pharmacol. 2010, 3:12-29.
5. Crawford F.C., Wood M.L., Wilson S.E., Mathura V.S., Hollen T.R., Geall F., Kolippakkam D.N., Mullan M.J. Cocaine induced inflammatory response in human neuronal progenitor cells. J. Neurochem. 2006, 97:662-674.
6. Cunha P.J., Nicastri S., Gomes L.P., Moino R.M., Peluso M.A. Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings. Rev. Bras. Psiquiatr. 2004, 26:103-106.
7. De Kloet E.R., Oitzl M.S., Schöbitz B. Cytokines and the brain corticosteroid receptor balance: relevance to pathophysiology of neuroendocrine-immune communication. Psychoneuroendocrinology 1994, 19:121-134.
8. Dietrich J.B., Mangeol A., Revel M.O., Burgun C., Aunis D., Zwiller J. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology 2005, 48:965-974.
9. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 2000, 48:732-739.
10. Fox H.C., D'Sa C., Kimmerling A., Siedlarz K.M., Tuit K.L., Stowe R., Sinha R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum. Psychopharmacol. 2012, 27:156-166.
11. Fumagalli F., Di Pasquale L., Caffino L., Racagni G., Riva M.A. Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur. J. Neurosci. 2007, 26:2756-2763.
12. Garcia R.C., Dati L.M., Fukuda S., Torres L.H., Moura S., de Carvalho N.D., Carrettiero D.C., Camarini R., Levada-Pires A.C., Yonamine M., Neto O.N., Abdalla F.M., Sandoval M.R., Afeche S.C., Marcourakis T. The neurotoxicity of anhydroecgonine methyl ester, a crack cocaine pyrolysis product. Toxicol. Sci. 2012, 128:223-234.
13. Graham D.L., Edwards S., Bachtell R.K., DiLeone R.J., Rios M., Self D.W. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat. Neurosci. 2007, 10:1029-1037.
14. Grande I., Magalhaes P.V., Kunz M., Vieta E., Kapczinski F. Mediators of allostasis and systemic toxicity in bipolar disorder. Physiol. Behav. 2012, 106:46-50.
15. Hall F.S., Drgonova J., Goeb M., Uhl G.R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 2003, 28:1485-1490.
16. Hermida-Ameijeiras A., Méndez-Alvarez E., Sánchez-Iglesias S., Sanmartín-Suárez C., Soto-Otero R., Autoxidation MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem. Int. 2004, 45:103-116.
17. Juster R.P., McEwen B.S., Lupien S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35:2-16.
18. Kapczinski F., Vieta E., Andreazza A.C., Frey B.N., Gomes F.A., Tramontina J., Kauer-Sant'anna M., Grassi-Oliveira R., Post R.M. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 2008, 32:675-692.
19. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., Pasquali M., Quevedo J., Gama C.S., Post R.R. A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol. Psychiatry 2010, 15:784-786.
20. Kapczinski F., Dal-Pizzol F., Teixeira A.L., Magalhaes P.V.S., Kauer-Sant'Anna M., Klamt F., Moreira J.C.F., Pasquali M.A.D., Fries G.R., Quevedo J., Gama C.S., Post R. Peripheral biomarkers and illness activity in bipolar disorder. J. Psychiatr. Res. 2011, 45:156-161.
21. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 2002, 328:261-264.
22. Kessler F.H., Woody G., Portela L.V., Tort A.B., De Boni R., Peuker A.C., Genro V., von Diemen L., de Souza D.O., Pechansky F. Brain injury markers (S100B and NSE) in chronic cocaine dependents. Rev. Bras. Psiquiatr. 2007, 29:134-139.
23. Knuepfer M.M., Bloodgood T.A., Matuschak G.M., Lechner A.J. Cocaine enhances susceptibility to endotoxemic shock in a subset of rats. Crit. Care Med. 2004, 32:175-183.
24. Koob G.F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 2009, 42:S32-S41.
25. Kubera M., Filip M., Budziszewska B., Basta-Kaim A., Wydra K., Leskiewicz M., Regulska M., Jaworska-Feil L., Przegalinski E., Machowska A., Lason W. Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration. J. Pharmacol. Sci. 2008, 107:361-369.
26. Lang U.E., Hellweg R., Seifert F., Schubert F., Gallinat J. Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biol. Psychiatry 2007, 62:530-535.
27. Lee K.W., Kim Y., Kim A.M., Helmin K., Nairn A.C., Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:3399-3404.
28. Leite M.C., Andrade A.G. Cocaína e crack. Dos fundamentos ao tratamento 1999, Artmed, Porto Alegre. A.G. Andrade (Ed.).
29. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990, 186:464-478.
30. Lu L., Dempsey J., Liu S.Y., Bossert J.M., Shaham Y. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J. Neurosci. 2004, 24:1604-1611.
31. Magalhaes P.V.S., Fries G.R., Kapczinski F. Peripheral markers and the pathophysiology of bipolar disorder. Revista De Psiquiatria Clinica 2012, 39:60-67.
32. McCarthy D.M., Brown A.N., Bhide P.G. Regulation of BDNF expression by cocaine. Yale J. Biol. Med. 2012, 85:437-446.
33. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22:108-124.
34. Moritz F., Monteil C., Isabelle M., Bauer F., Renet S., Mulder P., Richard V., Thuillez C. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res. 2003, 59:834-843.
35. Narvaez J.C., Magalhães P.V., Trindade E.K., Vieira D.C., Kauer-Sant'anna M., Gama C.S., von Diemen L., Kapczinski N.S., Kapczinski F. Childhood trauma, impulsivity, and executive functioning in crack cocaine users. Compr. Psychiatry 2012, 53:238-244.
36. Ndikum-Moffor F.M., Schoeb T.R., Roberts S.M. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J. Pharmacol. Exp. Ther. 1998, 284:413-419.
37. Numa R., Kohen R., Poltyrev T., Yaka R. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 2008, 155:649-658.
38. Pace-Schott E.F., Morgan P.T., Malison R.T., Hart C.L., Edgar C., Walker M., Stickgold R. Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am. J. Drug Alcohol Abuse 2008, 34:109-121.
39. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26:761-788.
40. Russo S.J., Mazei-Robison M.S., Ables J.L., Nestler E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 2009, 56:73-82.
41. Russo S.J., Dietz D.M., Dumitriu D., Morrison J.H., Malenka R.C., Nestler E.J. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci. 2010, 33:267-276.
42. Sarti F., Borgland S.L., Kharazia V.N., Bonci A. Acute cocaine exposure alters spine density and long-term potentiation in the ventral tegmental area. Eur. J. Neurosci. 2007, 26:749-756.
43. Schroeder F.A., Penta K.L., Matevossian A., Jones S.R., Konradi C., Tapper A.R., Akbarian S. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 2008, 33:2981-2992.
44. Smythies J., Galzigna L.L. The oxidative metabolism of catecholamines in the brain: a review. Biochim. Biophys. Acta 1998, 1380:159-162.
45. Tanaka J., Horiike Y., Matsuzaki M., Miyazaki T., Ellis-Davies G.C., Kasai H. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 2008, 319:1683-1687.
46. Turnbull A.V., Rivier C. Regulation of the HPA axis by cytokines. Brain Behav. Immun. 1995, 9:253-275.
47. Vaziri N.D. Causal link between oxidative stress, inflammation, and hypertension. Iran J. Kidney Dis. 2008, 2:1-10.
48. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 1966, 99:667-676.